These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 29527914)
1. Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Kala P; Sedláková L; Škaroupková P; Kopkan L; Vaňourková Z; Táborský M; Nishiyama A; Hwang SH; Hammock BD; Sadowski J; Melenovský V; Imig JD; Červenka L Physiol Res; 2018 Jul; 67(3):401-415. PubMed ID: 29527914 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula. Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula. Červenka L; Melenovský V; Husková Z; Sporková A; Bürgelová M; Škaroupková P; Hwang SH; Hammock BD; Imig JD; Sadowski J Physiol Res; 2015; 64(6):857-73. PubMed ID: 26047375 [TBL] [Abstract][Full Text] [Related]
4. Sex-linked differences in the mortality in Ren-2 transgenic hypertensive rats with aorto-caval fistula: effects of treatment with angiotensin converting enzyme alone and combined with inhibitor of soluble epoxide hydrolase. Kala P; Červenka L; Škaroupková P; Táborský M; Kompanowska-Jezierska E; Sadowski J Physiol Res; 2019 Aug; 68(4):589-601. PubMed ID: 31177795 [TBL] [Abstract][Full Text] [Related]
5. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease. Čertíková Chábová V; Kujal P; Škaroupková P; Varňourková Z; Vacková Š; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Baranowska I; Hwang SH; Hammock BD; Imig JD; Tesař V; Červenka L Kidney Blood Press Res; 2018; 43(2):329-349. PubMed ID: 29529602 [TBL] [Abstract][Full Text] [Related]
6. Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure. Sporková A; Husková Z; Škaroupková P; Rami Reddy N; Falck JR; Sadowski J; Červenka L Physiol Res; 2017 Mar; 66(1):29-39. PubMed ID: 27782740 [TBL] [Abstract][Full Text] [Related]
7. Sex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula. Červenka L; Škaroupková P; Kompanowska-Jezierska E; Sadowski J Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):883-95. PubMed ID: 27385471 [TBL] [Abstract][Full Text] [Related]
8. Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats. Čertíková Chábová V; Kujal P; Vaňourková Z; Škaroupková P; Sadowski J; Kompanowska-Jezierska E; Tesař V; Hammock B; Imig J; Maxová H; Červenka L; Vaněčková I Kidney Blood Press Res; 2019; 44(6):1493-1505. PubMed ID: 31770762 [TBL] [Abstract][Full Text] [Related]
9. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension. Kala P; Gawrys O; Miklovič M; Vaňourková Z; Škaroupková P; Jíchová Š; Sadowski J; Kompanowska-Jezierska E; Walkowska A; Veselka J; Táborský M; Maxová H; Vaněčková I; Červenka L J Hypertens; 2023 Jan; 41(1):99-114. PubMed ID: 36204993 [TBL] [Abstract][Full Text] [Related]
10. AT Kratky V; Vanourkova Z; Sykora M; Bacova BS; Hruskova Z; Kikerlova S; Huskova Z; Kopkan L Sci Rep; 2021 Feb; 11(1):4271. PubMed ID: 33608612 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological Blockade of Soluble Epoxide Hydrolase Attenuates the Progression of Congestive Heart Failure Combined With Chronic Kidney Disease: Insights From Studies With Fawn-Hooded Hypertensive Rats. Vacková Š; Kopkan L; Kikerlová S; Husková Z; Sadowski J; Kompanowska-Jezierska E; Hammock BD; Imig JD; Táborský M; Melenovský V; Červenka L Front Pharmacol; 2019; 10():18. PubMed ID: 30728778 [TBL] [Abstract][Full Text] [Related]